Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
Titel:
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
Auteur:
Matulonis, U.A. Penson, R.T. Domchek, S.M. Kaufman, B. Shapira-Frommer, R. Audeh, M.W. Kaye, S. Molife, L.R. Gelmon, K.A. Robertson, J.D. Mann, H. Ho, T.W. Coleman, R.L.